{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T08:36:01Z","timestamp":1787646961542,"version":"build-2736575974"},"reference-count":35,"publisher":"Europa Digital & Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.4244\/eijy15m05_03","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T02:22:11Z","timestamp":1466389331000},"page":"366-374","source":"Crossref","is-referenced-by-count":22,"title":["Statin use prior to angiography for the prevention of contrast-induced acute kidney injury: a meta-analysis of 19 randomised trials"],"prefix":"10.4244","volume":"12","author":[{"given":"Keith","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabia","family":"Razi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Sum","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Hiremath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somjot S.","family":"Brar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2774","reference":[{"key":"key-20166191770-0","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1161\/CIRCULATIONAHA.105.595090","article-title":"Contrast-induced nephropathy: a clinical and evidence-based approach.","volume":"113","author":"Tepel M.","year":"2006","journal-title":"Circulation."},{"key":"key-20166191770-1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1681\/ASN.V111177","article-title":"Contrast nephropathy.","volume":"11","author":"Murphy SW.","year":"2000","journal-title":"J Am Soc Nephrol."},{"key":"key-20166191770-2","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","article-title":"Contrast-induced acute kidney injury.","volume":"51","author":"McCullough PA.","year":"2008","journal-title":"J Am Coll Cardiol."},{"key":"key-20166191770-3","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.jacc.2004.06.075","article-title":"Contrast nephropathy: review focusing on prevention.","volume":"44","author":"Maeder M.","year":"2004","journal-title":"J Am Coll Cardiol."},{"key":"key-20166191770-4","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","article-title":"Hospital-acquired renal insufficiency.","volume":"39","author":"Nash K.","year":"2002","journal-title":"Am J Kidney Dis."},{"key":"key-20166191770-5","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","article-title":"Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial.","volume":"383","author":"Brar SS.","year":"2014","journal-title":"Lancet."},{"key":"key-20166191770-6","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1001\/jama.300.9.1038","article-title":"Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial.","volume":"300","author":"Brar SS.","year":"2008","journal-title":"JAMA."},{"key":"key-20166191770-7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jacc.2013.09.017","article-title":"Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.","volume":"63","author":"Han Y.","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"key-20166191770-8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jacc.2013.04.105","article-title":"Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).","volume":"63","author":"Leoncini M.","year":"2014","journal-title":"J Am Coll Cardiol."},{"key":"key-20166191770-9","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1161\/CIRCULATIONAHA.112.103317","article-title":"Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury.","volume":"126","author":"Quintavalle C.","year":"2012","journal-title":"Circulation."},{"key":"key-20166191770-10","first-page":"1600","article-title":"[Atorvastatin prevents contrast agent-induced renal injury in patients undergoing coronary angiography by inhibiting oxidative stress].","volume":"32","author":"Cao S.","year":"2012","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao."},{"key":"key-20166191770-11","first-page":"17_S","article-title":"High dose Atorvastatin Pretreatment for Preventing Contrast-Induced Nephropathy in Patients Receiving Primary Percutaneous Coronary Intervention: Prespecified Substudy of a Prospective Randomized Clinical trial.","volume":"60","author":"Jo SH.","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"key-20166191770-12","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000339472","article-title":"Beneficial effects of high-dose atorvastatin pretreatment on renal function in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention.","volume":"122","author":"Li W.","year":"2012","journal-title":"Cardiology."},{"key":"key-20166191770-13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S2214-1235(15)30069-7","article-title":"Impact on renal function of rosuvastatin preload prior to elective percutaneous coronary intervention in chronic statin users.","volume":"20","author":"Oliveira MS de.","year":"2012","journal-title":"Rev Bras Cardiol Invasiva [online]."},{"key":"key-20166191770-14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2011.03.001","article-title":"Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.","volume":"108","author":"Patti G.","year":"2011","journal-title":"Am J Cardiol."},{"key":"key-20166191770-15","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2011-300867.673","article-title":"Efficacy of short-term high-dose atorvastatin for prevention of contrast induced nephropathy in patients with ST segment elevation myocardial infarction undergoing percutaneous coronary intervention.","author":"Miao Y.","year":"2011","journal-title":"Heart Conference: 22nd Great Wall International Congress of Cardiology and Asia Pacific Heart Congress 2011. Beijing, China"},{"key":"key-20166191770-16","first-page":"1041","article-title":"Usefulness of statin pretreatment to prevent contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention in real world. European Society of Cardiology, ESC Congress 2011, Paris, France.","volume":"32 (Abstract Supplement)","author":"Ha SJ.","year":"2011","journal-title":"Eur Heart J."},{"key":"key-20166191770-17","first-page":"448","article-title":"[Prevention of contrast-induced nephropathy using high-dose atorvastatin in patients with coronary heart disease undergoing elective percutaneous coronary intervention].","volume":"24","author":"Hua XP.","year":"2010","journal-title":"Milit Med J South China."},{"key":"key-20166191770-18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1177\/0003319710364216","article-title":"Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography.","volume":"61","author":"Ozhan H.","year":"2010","journal-title":"Angiology."},{"key":"key-20166191770-19","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/MBC.0b013e32834014a4","article-title":"Prevention of contrast-induced impairment of renal function by short-term or long-term statin therapy in patients undergoing elective coronary angiography.","volume":"21","author":"Acikel S.","year":"2010","journal-title":"Blood Coagul Fibrinolysis."},{"key":"key-20166191770-20","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.amjcard.2009.09.026","article-title":"Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.","volume":"105","author":"Toso A.","year":"2010","journal-title":"Am J Cardiol."},{"key":"key-20166191770-21","first-page":"520","article-title":"[Effect of different doses of Atorvastatin in contrast-induced nephropathy].","volume":"7","author":"Yu DJ.","year":"2010","journal-title":"Chin J Interv Imaging."},{"key":"key-20166191770-22","first-page":"394","article-title":"[Efficacy of high dose atorvastatin on preventing contrast induced nephropathy in patients underwent coronary angiography].","volume":"37","author":"Zhou X.","year":"2009","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi."},{"key":"key-20166191770-23","article-title":"[Effect of atorvastatin on renal function in patients given contrast medium after interventional procedures].","volume":"20","author":"Wang Z.","year":"2009","journal-title":"Med J Chin Peoples Armed Police forces."},{"key":"key-20166191770-24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.amjcard.2009.04.014","article-title":"Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.","volume":"104","author":"Xinwei J.","year":"2009","journal-title":"Am J Cardiol."},{"key":"key-20166191770-25","doi-asserted-by":"crossref","first-page":"499.e1","DOI":"10.1016\/j.ahj.2007.11.042","article-title":"Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial--a randomized controlled study.","volume":"155","author":"Jo SH.","year":"2008","journal-title":"Am Heart J."},{"key":"key-20166191770-26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad AR.","year":"1996","journal-title":"Control Clin Trials."},{"key":"key-20166191770-27","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials.","volume":"7","author":"DerSimonian R.","year":"1986","journal-title":"Control Clin Trials."},{"key":"key-20166191770-28","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses.","volume":"354","author":"Moher D.","year":"1999","journal-title":"Lancet."},{"key":"key-20166191770-29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0195-668X(02)00419-0","article-title":"Statin effects beyond lipid lowering--are they clinically relevant?","volume":"24","author":"Bonetti PO.","year":"2003","journal-title":"Eur Heart J."},{"key":"key-20166191770-30","doi-asserted-by":"publisher","first-page":"F53","DOI":"10.1152\/ajprenal.00041.2008","article-title":"Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability.","volume":"295","author":"Zhou MS.","year":"2008","journal-title":"Am J Physiol Renal Physiol."},{"key":"key-20166191770-31","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.amjcard.2007.08.030","article-title":"Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.","volume":"101","author":"Patti G.","year":"2008","journal-title":"Am J Cardiol."},{"key":"key-20166191770-32","doi-asserted-by":"publisher","first-page":"H377","DOI":"10.1152\/ajpheart.00289.2012","article-title":"Statin therapy lowers muscle sympathetic nerve activity and oxidative stress in patients with heart failure.","volume":"303","author":"Deo SH.","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"key-20166191770-33","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.","volume":"359","author":"Ridker PM.","year":"2008","journal-title":"N Engl J Med."},{"key":"key-20166191770-34","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1097\/01.ASN.0000026609.45827.3D","article-title":"Postischemic acute renal failure is reduced by short-term statin treatment in a rat model.","volume":"13","author":"Gueler F.","year":"2002","journal-title":"J Am Soc Nephrol."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T19:32:47Z","timestamp":1656703967000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/100th_issue\/59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["20140626-01"],"URL":"https:\/\/doi.org\/10.4244\/eijy15m05_03","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}